Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.

BACKGROUND & AIMS Pancreatic cancer creates desmoplasia by stimulating stellate cells (PSCs), thereby influencing tumor aggressiveness. The aim of this study was to analyze the impact of the PSC-specific matrix protein periostin on tumor responses to radiochemotherapy. METHODS PSCs and cancer cells in primary and metastatic lesions of patients treated with or without neoadjuvant radiochemotherapy were evaluated by immunohistochemistry. Periostin messenger-RNA levels determined by quantitative reverse-transcription polymerase chain reaction were correlated to patient survival. Interactions between PSCs and cancer cells and the effects of periostin in modulating cellular responses under conditions of hypoxia, starvation, and radiochemotherapy were assessed by immunoblotting and by growth, clonogenicity, and invasion assays. RESULTS Periostin messenger-RNA levels were elevated 42-fold in cancer, and patients with increased expression had a tendency toward shorter survival (19 vs 12 months; P = .14). Stromal cells were the only source of periostin in the pancreas and in metastatic sites. Cancer cell supernatants stimulated periostin secretion from PSCs. Recombinant periostin increased alpha-smooth muscle actin, periostin, collagen-1, fibronectin, and transforming growth factor-beta1 expression while decreasing PSC invasiveness. These effects were reversed by silencing periostin expression and secretion by small interfering RNA transfection. In cancer cells, periostin stimulated growth and conferred resistance to starvation and hypoxia. In addition, the periostin downstream target collagen-1 significantly increased chemoresistance. CONCLUSIONS Once stimulated by cancer cells, PSCs remain active via an autocrine periostin loop even under radiotherapy and produce excessive extracellular matrix proteins, creating a tumor-supportive microenvironment. Increased periostin expression may therefore reflect a more aggressive tumor phenotype.

[1]  H. Kern,et al.  Distribution of Extracellular Matrix Proteins in Pancreatic Ductal Adenocarcinoma and Its Influence on Tumor Cell Proliferation in Vitro , 1987, Pancreas.

[2]  J. Wrana,et al.  Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. , 1991, The Journal of biological chemistry.

[3]  T. Inoue,et al.  Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? , 1994, Archives of surgery.

[4]  T. Akimoto,et al.  Effect of radiation on the expression of E-cadherin and alpha-catenin and invasive capacity in human lung cancer cell line in vitro. , 1998, International journal of radiation oncology, biology, physics.

[5]  A. Buck,et al.  Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. , 2005, Gastroenterology.

[6]  H. Friess,et al.  Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer. , 1999, Biochemical and biophysical research communications.

[7]  S. Friedman,et al.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. , 2001, The Journal of clinical investigation.

[8]  M. Löhr,et al.  Expression and Function of Receptors for Extracellular Matrix Proteins in Human Ductal Adenocarcinomas of the Pancreas , 1996, Pancreas.

[9]  C. Thompson,et al.  Akt-dependent transformation: there is more to growth than just surviving , 2005, Oncogene.

[10]  N. Yoshioka,et al.  Periostin is down‐regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells , 2005, International journal of cancer.

[11]  Ryan M. Anderson,et al.  Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. , 2004, Cancer cell.

[12]  D E Ingber,et al.  Role of basal lamina in neoplastic disorganization of tissue architecture. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Piechocki,et al.  Radiation-induced increase in expression of the alpha IIb beta 3 integrin in melanoma cells: effects on metastatic potential. , 1992, Radiation research.

[14]  A. Koong,et al.  Pancreatic tumors show high levels of hypoxia. , 2000, International journal of radiation oncology, biology, physics.

[15]  R. Schmid,et al.  Identification, culture, and characterization of pancreatic stellate cells in rats and humans. , 1998, Gastroenterology.

[16]  H. Kitano.  Cancer as a robust system: implications for anticancer therapy , 2004, Nature Reviews Cancer.

[17]  P. Hein,et al.  Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.

[18]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[19]  A. Cubilla,et al.  Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. , 1976, Cancer research.

[20]  Y Sun,et al.  Gamma‐irradiation induces matrix metalloproteinase II expression in a p53‐dependent manner , 2000, Molecular carcinogenesis.

[21]  H. Auer,et al.  Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes , 2004, Cancer Research.

[22]  R. Lunevicius,et al.  Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer , 2001, Journal of Cancer Research and Clinical Oncology.

[23]  K. Tsuchida,et al.  Tumor-Stroma Interaction of Human Pancreatic Cancer: Acquired Resistance to Anticancer Drugs and Proliferation Regulation Is Dependent on Extracellular Matrix Proteins , 2004, Pancreas.

[24]  R. Schmid,et al.  Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. , 2001, American journal of physiology. Cell physiology.

[25]  P Vaupel,et al.  Biological consequences of tumor hypoxia. , 2001, Seminars in oncology.

[26]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[27]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[28]  A. Harris,et al.  Expression of hypoxia‐inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas , 2005, Histopathology.

[29]  Eric R. Pianka,et al.  On r- and K-Selection , 1970, The American Naturalist.

[30]  T. Tlsty,et al.  Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.

[31]  P. Lizardi,et al.  Alterations in DNA Repair Gene Expression under Hypoxia: Elucidating the Mechanisms of Hypoxia‐Induced Genetic Instability , 2005, Annals of the New York Academy of Sciences.

[32]  Lynda F. Bonewald,et al.  Identification and Characterization of a Novel Protein, Periostin, with Restricted Expression to Periosteum and Periodontal Ligament and Increased Expression by Transforming Growth Factor β , 1999 .

[33]  P. Vaupel,et al.  Hypoxic cervical cancers with low apoptotic index are highly aggressive. , 1999, Cancer research.

[34]  I. Tai,et al.  Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies. , 2005, Carcinogenesis.

[35]  D. Fishman,et al.  Periostin Secreted by Epithelial Ovarian Carcinoma Is a Ligand for V 3 and V 5 Integrins and Promotes Cell Motility 1 , 2002 .

[36]  H. Friess,et al.  Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis , 2005, Oncogene.

[37]  C. Thompson,et al.  The survival kinases Akt and Pim as potential pharmacological targets. , 2005, The Journal of clinical investigation.

[38]  Hans A. Kestler,et al.  Transcriptome analysis of human hepatic and pancreatic stellate cells: organ-specific variations of a common transcriptional phenotype , 2005, Journal of Molecular Medicine.

[39]  K. Kinzler,et al.  Landscaping the Cancer Terrain , 1998, Science.

[40]  S. Ashley,et al.  c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components. , 2004, Biochemical and biophysical research communications.

[41]  M. Korsten,et al.  Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis , 2002, Gut.

[42]  N. Sohara,et al.  Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate. , 2002, Journal of hepatology.

[43]  M. W. Büchler,et al.  Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer , 2003, Cellular and Molecular Life Sciences CMLS.

[44]  T. Yoneda,et al.  Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A , 2000, Journal of Bone and Mineral Metabolism.

[45]  Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. , 1994, British journal of cancer.

[46]  J. Rode,et al.  Distribution of type IV collagen in pancreatic adenocarcinoma and chronic pancreatitis. , 1994, International journal of experimental pathology.

[47]  R. Bell,et al.  Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. , 2002, Surgery.

[48]  C Caldas,et al.  Allelotype of pancreatic adenocarcinoma. , 1994, Cancer research.

[49]  J. Iredale,et al.  Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma , 2004, Clinical Cancer Research.

[50]  K. Ohuchida,et al.  Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. , 2004, Cancer research.

[51]  M. Korsten,et al.  Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis , 1999, Gut.

[52]  M. Skobe,et al.  Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  N R Lemoine,et al.  Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the β4 integrin and the PI3k pathway , 2007, Oncogene.

[54]  G. Adler,et al.  Platelet-Derived Growth Factors Stimulate Proliferation and Extracellular Matrix Synthesis of Pancreatic Stellate Cells: Implications in Pathogenesis of Pancreas Fibrosis , 2000, Laboratory Investigation.

[55]  M. Yutsudo,et al.  Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 gene. , 2002, Experimental cell research.

[56]  K. Camphausen,et al.  Radiation therapy to a primary tumor accelerates metastatic growth in mice. , 2001, Cancer research.

[57]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.